Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Drug Prices
Mallinckrodt Sues CMS and HHS Over Rebates
Recently, a subsidiary of Mallinckrodt PLC, Mallinckrodt ARD LLC, filed a lawsuit against the United States Department of Health…
Study Shows that Patients’ Out-of-Pocket Costs for Neurology Drugs Have…
The journal Neurology recently published an article by lead author Brian Callaghan, MD at the University of Michigan, reporting…
Federal Judge Orders HHS to Develop Remedial Measures for 340B Drug Cuts
A federal judge ordered HHS to come up with a remedial measure that would address hospital payment cuts under Medicare's 340B drug…
Heritage Pharmaceuticals Admits to Price Fixing, Agrees to Cooperate with…
Recently, it was announced that Heritage Pharmaceuticals, Inc., a generic pharmaceutical company, was charged with conspiring with…
Maine Governor Signs Prescription Drug Reform Into Law
On June 24, 2019, Maine Governor Janet Mills signed a four-bill prescription drug reform package into law that would allow the…
Maryland Creates Prescription Drug Affordability Board for Setting Price…
As we have previously reported, the federal government has taken an acute interest in pharmaceutical drug pricing, resulting in a…
Drug Manufacturers File Suit to Block HHS Rule Requiring That Drug Prices…
On June 14, 2019, several pharmaceutical companies filed suit against the Department of Health and Human Services (“HHS”), seeking…
New Colorado Law Requires Manufacturer Sales Reps to Provide Prescribers…
Colorado Governor Jared S. Polis signed an Act into law that starting August 2nd 2019 requires drug manufacturers to make certain…
Senate Health Subcommittee Releases Discussion Draft of Legislation to…
Senate Health Committee Chairman Lamar Alexander (R-TN) and Ranking Member Patty Murray (D-WA) released bipartisan discussion…
Biopharma Executives Answer Senate Finance Committee Questions on Policies…
During the Senate Finance Committee hearing earlier this year addressing Drug Pricing in America, the committee posed questions to…